Professor of Radiation Oncology, University Tex San Antonio
Radiation Oncology
Dr. Chul S. Ha, MD
|
|
Give Review
Doctor Chul S. Ha, MD is an expert in the field of Radiation Oncology. He attended Harvard Medical School. Harvard Medical School is a top medical university. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. He has 1 awards "Top Doctors:SE Texas". Chul has written publications. He has 100 publications published with PubMed. The lastest paper is: 'Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: a preliminary ...' He accepts Medicare.
Publications
- Persistent Disparities in Hispanics with Cervical Cancer in a Major City.
- Image-guided radiation therapy in lymphoma management.
- Pathological characteristics of low risk prostate cancer based on totally embedded prostatectomy specimens.
- ACR Appropriateness Criteria Follow-up of Hodgkin Lymphoma.
- Tolerance of Phellodendron amurense Bark Extract (Nexrutine®) in Patients with Human Prostate Cancer.
- ACR Appropriateness Criteria: Localized nodal indolent lymphoma.
- Incidence of gastric involvement in patients with nongastrointestinal extranodal marginal zone lymphoma.
- Solitary plasmacytomas: Outcome and prognostic factors after definitive radiation therapy.
- Delivery of four-dimensional radiotherapy with TrackBeam for moving target using an AccuKnife dual-layer MLC: dynamic phantoms study.
- Fludarabine allows dose reduction for total body irradiation in pediatric hematopoietic stem cell transplantation.
- Multiple myeloma of the cervical spine: treatment strategies for pain and spinal instability.
- Lymphoma.
- Radiotherapy and Hodgkin's lymphoma.
- A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treat...
- Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma.
- The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia.
- Second malignancies after chemotherapy and radiotherapy for Hodgkin disease.
- Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reactio...
- Stage III follicular lymphoma: long-term follow-up and patterns of failure.
- Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective study.
- Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemothe...
- Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma.
- Importance of esophagogastroduodenoscopy in the evaluation of non-gastrointestinal mucosa-associated lymphoid tissue lymphoma.
- Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
- Clinical implications of incorporating heterogeneity corrections in mantle field irradiation.
- Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.
- An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
- Radiotherapy alone for lymphocyte-predominant Hodgkin's disease.
- International prognostic index-based outcomes for diffuse large B-cell lymphomas.
- The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma.
- European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin di...
- Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone.
- Results with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone followed by radiotherapy with or without prechemotherapy surgical deb...
- Commissioning an Elekta Versa HD linear accelerator.
- Dosimetric effect of photon beam energy on volumetric modulated arc therapy treatment plan quality due to body habitus in advanced prostate cancer.
- Multiple modality treatment of carcinoma cells with Pt(Rh-123)2 plus x-ray plus light.
- A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents.
- PET and SPECT imaging for stereotactic localization.
- The reliability of optimization under dose-volume limits.
- The effect on minimum tumor dose of restricting target-dose inhomogeneity in optimized three-dimensional treatment of lung cancer.
- Toxicity of repeated intravenous injection of gene therapeutics for X-CGD in mice.
- Gain in target dose from using Computer Controlled Radiation Therapy (CCRT) in the treatment of non-small cell lung cancer.
- Correlation of gallium-67 SPECT and CT findings in primary gynecologic lymphoma.
- Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or wit...
- Long-term results with radiotherapy for Stage I-II follicular lymphomas.
- Radiation-induced injury to the visual pathway.
- Non-Hodgkin's lymphomas involving the uterus: a clinicopathologic analysis of 26 cases.
- Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas.
- Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia.
- Nonnasopharyngeal lymphoepithelioma of the head and neck.
- Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy.
- Postoperative radiotherapy for cutaneous melanoma of the head and neck region.
- Radiation therapy for malignant lymphoma: enduring importance in the era of systemic therapy.
- Stage I Hodgkin disease: radiation therapy and chemotherapy at the University of Texas M. D. Anderson Cancer Center, 1996-1997.
- The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21).
- Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity.
- Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria.
- Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia.
- Localized primary malignant lymphoma of bone.
- Agreement rates among single photon emission computed tomography using gallium-67, computed axial tomography and lymphangiography for Hodgkin disease and correlation o...
- Localized non-Hodgkin lymphoma involving the thyroid gland.
- Clinical course of solitary extramedullary plasmacytoma.
- Primary non-Hodgkin lymphoma of the large bowel.
- Three-dimensional treatment planning for central lymphatic irradiation.
- Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment.
- Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy.
- Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-bas...
- Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas.
- Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: a preliminary ...
- Total body irradiation, fludarabine, melphalan, and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematologic malignancies.
- Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin''s l...
- Hematologic recovery after central lymphatic irradiation for patients with stage I-III follicular lymphoma.
- Fludarabine-based preparative protocol for unrelated donor cord blood transplantation in children: successful engraftment with minimal toxicity.
- Stages I-III follicular lymphoma: role of CT of the abdomen and pelvis in follow-up studies.
- Primary non-Hodgkin lymphoma of the small bowel.
- Nasal-type T/NK lymphomas: a clinicopathologic study of 13 cases.
- Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies.
- Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease.
- Utilization of thermoluminescent dosimetry in total skin electron beam radiotherapy of mycosis fungoides.
- Primary parotid lymphoma: the effect of International Prognostic Index on outcome.
- Patient dosimetry for total body irradiation using single-use MOSFET detectors.
- Mucosa-associated lymphoid tissue lymphoma with initial supradiaphragmatic presentation: natural history and patterns of disease progression.
- The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinum.
- Recovery of sperm production following radiation therapy for Hodgkin's disease after induction chemotherapy with mitoxantrone, vincristine, vinblastine, and prednisone...
- Salvage central lymphatic irradiation in follicular lymphomas following failure of chemotherapy: a feasibility study.
- Role of radiation therapy to the brain in leukemic patients with cranial nerve palsies in the absence of radiological findings.
- Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy.
- Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors.
- Localized primary non-Hodgkin lymphoma of the breast.
- Hodgkin's disease: correlation of clinical characteristics with probabilities for negative lymphangiogram vs. negative laparotomy findings in patients with Stage I sup...
- Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma.
- Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy.
- Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
- Mycosis fungoides with follicular mucinosis displaying aggressive tumor-stage transformation : successful treatment using radiation therapy plus oral bexarotene combin...
- Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomas.
- Pathologically proven cavernous angiomas of the brain following radiation therapy for pediatric brain tumors.
- Uncertainties in contemporary treatment of aggressive lymphomas.
- Imexon augments sensitivity of human lymphoma cells to ionizing radiation: in vitro experimental study.
- Human lymphoma cells develop resistance to radiation in the presence of astrocytes in vitro.
Schools
Harvard Medical School
New England Deaconess HospHarvard Med School
Joint Center Rad Therapy
Doctors Specialties
- Radiation Oncology
Accepted Insurances
- Aetna
- Assurant Health
- Blue Card PPO
- Blue Choice
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Choice Care PPO
- Preferred PPO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Wells Fargo Insurance
Awards
- Top Doctors:SE Texas
Education
-
Beth Israel Deaconess Medical Center -
Harvard Medical School
Hospital
-
South Texas Veterans Health Care System -
University Health System -
CHRISTUS Santa Rosa Health System
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1891894705 |
| Last Name Of The Provider | HA |
| First Name Of The Provider | CHUL |
| View All |
Similar Doctors
|
|
Dr. Nasser Nakissa, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sylvia Zubyk, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Gagnon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard R. Crownover, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robin S. Akins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joaquin G. Mira, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ying Li, MD |
|
|
Dr. Gary W. West, MD |
|
|
Dr. Jehee Choi, MD |
|
|
Dr. Elizabeth V. Maani, MD
This Doctor is OpenDoctor Recommended.
|